Accéder au contenu
Merck

Shaking alone induces de novo conversion of recombinant prion proteins to β-sheet rich oligomers and fibrils.

PloS one (2014-06-04)
Carol L Ladner-Keay, Bethany J Griffith, David S Wishart
RÉSUMÉ

The formation of β-sheet rich prion oligomers and fibrils from native prion protein (PrP) is thought to be a key step in the development of prion diseases. Many methods are available to convert recombinant prion protein into β-sheet rich fibrils using various chemical denaturants (urea, SDS, GdnHCl), high temperature, phospholipids, or mildly acidic conditions (pH 4). Many of these methods also require shaking or another form of agitation to complete the conversion process. We have identified that shaking alone causes the conversion of recombinant PrP to β-sheet rich oligomers and fibrils at near physiological pH (pH 5.5 to pH 6.2) and temperature. This conversion does not require any denaturant, detergent, or any other chemical cofactor. Interestingly, this conversion does not occur when the water-air interface is eliminated in the shaken sample. We have analyzed shaking-induced conversion using circular dichroism, resolution enhanced native acidic gel electrophoresis (RENAGE), electron microscopy, Fourier transform infrared spectroscopy, thioflavin T fluorescence and proteinase K resistance. Our results show that shaking causes the formation of β-sheet rich oligomers with a population distribution ranging from octamers to dodecamers and that further shaking causes a transition to β-sheet fibrils. In addition, we show that shaking-induced conversion occurs for a wide range of full-length and truncated constructs of mouse, hamster and cervid prion proteins. We propose that this method of conversion provides a robust, reproducible and easily accessible model for scrapie-like amyloid formation, allowing the generation of milligram quantities of physiologically stable β-sheet rich oligomers and fibrils. These results may also have interesting implications regarding our understanding of prion conversion and propagation both within the brain and via techniques such as protein misfolding cyclic amplification (PMCA) and quaking induced conversion (QuIC).

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Acetate de sodium, anhydrous, ReagentPlus®, ≥99.0%
Sigma-Aldrich
Acetate de sodium, puriss. p.a., ACS reagent, reag. Ph. Eur., anhydrous
Sigma-Aldrich
Acetate de sodium, ACS reagent, ≥99.0%
Sigma-Aldrich
Acetate de sodium, anhydrous, for molecular biology, ≥99%
Sigma-Aldrich
Acetate de sodium, >99%, FG
Sigma-Aldrich
Acetate de sodium, 99.995% trace metals basis
Sigma-Aldrich
Acetate de sodium, anhydrous, BioUltra, for luminescence, for molecular biology, ≥99.0% (NT)
Sigma-Aldrich
Acetate de sodium, anhydrous, free-flowing, Redi-Dri, ACS reagent, ≥99.0%
Sigma-Aldrich
Sodium acetate solution, BioUltra, for molecular biology, ~3 M in H2O
Sigma-Aldrich
Acetate de sodium, powder, BioReagent, suitable for electrophoresis, suitable for cell culture, suitable for insect cell culture, ≥99%
USP
Acetate de sodium, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Acetate de sodium, BioXtra, ≥99.0%
Sigma-Aldrich
Acetate de sodium, meets USP testing specifications, anhydrous